<DOC>
	<DOCNO>NCT02317133</DOCNO>
	<brief_summary>The primary objective study search evidence quantitative functional defect plasma regulatory T cell ( Tregs ) pediatric patient Henoch Schönlein Purpura ( HSP ) compare control population .</brief_summary>
	<brief_title>Study Role Regulator T Cells Pathophysiology Childhood Henoch Schönlein Purpura</brief_title>
	<detailed_description>The secondary questions/objectives study : A . During inflammatory HSP flare , quantitative / qualitative defect plasma Tregs ? Are blood anomaly real due modification distribution theses cell localize site ? B . In asymptomatic phase , quantitative functional abnormality among Tregs subject HSP compare healthy control subject ? C. Are Treg abnormality associate modification blood cell lineage , include B cell secrete IgA abnormally glycosylated IgA1 , secretion cytokine acute relapse asymptomatic phase ? D. Can streptococcus oral digestive pathogen ( bacterial viral ) ( suggest chronic disease rheumatoid arthritis ) provoke ( via stimulation Th3 ) isotype commutation towards secretion IgA1 origin HSP ? Does HSP intestinal damage imbalance intestinal microbiota allow translocation intestinal microorganism sustain stimulation ?</detailed_description>
	<mesh_term>Purpura</mesh_term>
	<mesh_term>Purpura , Schoenlein-Henoch</mesh_term>
	<criteria>General inclusion criterion subpopulation include study The child ( age comprehensionskillappropriate information ) parent ( person exercise parental authority ) inform implementation study , objective , constraint patient right The child ( depend age ) parent ( person exercise parental authority ) give free informed consent sign consent The patient must insure beneficiary health insurance plan Inclusion criterion population A : Henoch Schönlein purpura , acute episodes The diagnosis Henoch Schönlein purpura make physician accord EULAR / PRES / PRINTO 2010 criterion ( purpura predominantly low limb associate one follow criterion : abdominal pain , arthralgia arthritis , kidney damage suggestive histology ( immune deposit dominate Immunoglobulin A ( IgA ) ) The patient treat via immunosuppression ( steroids immunosuppressive / biotherapy ) treat like least 15 day Inclusion criterion population B : Henoch Schönlein purpura remission The diagnosis Henoch Schönlein purpura make physician accord EULAR / PRES / PRINTO 2010 criteria The patient Henoch Schönlein purpura episode past , long symptom disease The patient treat via immunosuppression ( steroids immunosuppressive / biotherapy ) treat like least 15 day Inclusion criterion population C : control Subjects free infectious , inflammatory autoimmune disease Candidates elective surgery ( circumcision , urological surgery , removal tonsil adenoid ) The patient participate another interventional study exclusion period determine previous study The child refuse participate study Parents ( person parental responsibility ) refuse sign consent It impossible correctly inform patient his/her parent ( person parental authority ) The patient another inflammatory autoimmune disease Patient immunosuppressive / biotherapy treatment</criteria>
	<gender>All</gender>
	<minimum_age>3 Years</minimum_age>
	<maximum_age>17 Years</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>Tregs</keyword>
	<keyword>bacterial translocation</keyword>
	<keyword>cytokine</keyword>
</DOC>